| RS2528256187 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528256277 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2528256357 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528256387 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2528256417 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528256600 |
USH2A
|
Health Risk |
Likely pathogenic |
USH2A-related disorder, USH2A-related disorder |
| RS2528256628 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2528256644 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2528257059 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528257076 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2528257197 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2, Usher syndrome type 2A |
| RS2528261065 |
GGPS1
|
Health Risk |
Likely pathogenic |
Myopathy with tubular aggregates, Myopathy with tubular aggregates |
| RS2528278346 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2528278649 |
SGCG
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2528279313 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2528279555 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2528280263 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2528281424 |
DENND5A
|
Health Risk |
Pathogenic |
— |
| RS2528283195 |
NBAS
|
Health Risk |
Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS2528287611 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS2528295554 |
RYR2
|
Health Risk |
Pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2528301563 |
SEMA4A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2528308020 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
— |
| RS2528308185 |
EIF2AK3
|
Health Risk |
Likely pathogenic |
Wolcott-Rallison dysplasia, Wolcott-Rallison dysplasia |
| RS2528308360 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2528308390 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2528309114 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS2528311007 |
BOLA3
|
Health Risk |
Likely pathogenic |
Multiple mitochondrial dysfunctions syndrome 2, Multiple mitochondrial dysfunctions syndrome 2 |
| RS2528319905 |
SPR
|
Health Risk |
Likely pathogenic |
Dopa-responsive dystonia due to sepiapterin reductase deficiency, Dopa-responsive dystonia due to sepiapterin reductase deficiency |
| RS2528336317 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2528336328 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2528337010 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2528353811 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528367903 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528375213 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528377417 |
COQ8A
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS2528379037 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2528380839 |
COQ8A
|
Health Risk |
Pathogenic |
— |
| RS2528380932 |
COQ8A
|
Health Risk |
Pathogenic |
— |
| RS2528381693 |
PRUNE1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, hypotonia |
| RS2528382225 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS2528389328 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528389720 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528389966 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528390555 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2528390756 |
COQ8A
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS2528396616 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS2528396653 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528396904 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2528396945 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary cancer-predisposing syndrome |
| RS2528397182 |
CENPF
|
Health Risk |
Likely pathogenic |
Stromme syndrome, Stromme syndrome |
| RS2528397232 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528397405 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528397565 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528397763 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528397772 |
OBSCN
|
Health Risk |
Pathogenic |
— |
| RS2528398503 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528398808 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528399077 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528399236 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2528399305 |
COQ8A
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS2528399365 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528399382 |
COQ8A
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS2528399484 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528399575 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528399751 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2528400092 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528400331 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528400393 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS2528400578 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528400662 |
CENPF
|
Health Risk |
Pathogenic |
— |
| RS2528400740 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms |
| RS2528400933 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms |
| RS2528401180 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528401276 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528401443 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528401479 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528401535 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528401829 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528401856 |
CENPF
|
Health Risk |
Likely pathogenic |
Stromme syndrome, Stromme syndrome |
| RS2528401900 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2528402457 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary cancer-predisposing syndrome |
| RS2528402587 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528402698 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2528402946 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528403306 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528403442 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528403709 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2528403825 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS2528403978 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528404053 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528404439 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528404670 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2528407432 |
RPIA
|
Health Risk |
Pathogenic |
— |
| RS2528412329 |
COQ8A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2528412539 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2528412973 |
COQ8A
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS2528423787 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2528426718 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528426837 |
NBAS
|
Health Risk |
Pathogenic |
— |